Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gossamer Bio (GOSS) Revenue (2022 - 2025)

Historic Revenue for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $13.3 million.

  • Gossamer Bio's Revenue rose 4023.21% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year decrease of 8096.31%. This contributed to the annual value of $90.7 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Gossamer Bio's Revenue stood at $13.3 million, which was up 4023.21% from $11.5 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Revenue registered a high of $95.8 million during Q2 2024, and its lowest value of -$14.6 million during Q4 2024.
  • Its 4-year average for Revenue is $9.8 million, with a median of -$3.5 million in 2022.
  • Data for Gossamer Bio's Revenue shows a peak YoY increase of 4023.21% (in 2025) and a maximum YoY decrease of 8801.26% (in 2025) over the last 5 years.
  • Quarter analysis of 4 years shows Gossamer Bio's Revenue stood at -$3.5 million in 2022, then decreased by 1.24% to -$3.5 million in 2023, then tumbled by 317.77% to -$14.6 million in 2024, then soared by 190.92% to $13.3 million in 2025.
  • Its last three reported values are $13.3 million in Q3 2025, $11.5 million for Q2 2025, and $9.9 million during Q1 2025.